BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cellerant Therapeutics, Inc. 

1531 Industrial Road

San Carlos  California  94070  U.S.A.
Phone: 650-232-2122 Fax: 650-232-5495


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Start Up





 Company News
Cellerant Therapeutics, Inc. To Present Phase 1 Clinical Data On Evaluation Of CLT-008 In Patients With Acute Myeloid Leukemia At The 2014 American Society of Hematology Annual Meeting 12/8/2014 7:28:57 AM
Bay Area's Cellerant Therapeutics, Inc. Awarded $47.5 Million From The U.S. Government 9/11/2014 6:17:48 AM
Cellerant Therapeutics, Inc. Announces Timothy Fong As Vice President Of Cellular Technologies And Jagath Reddy Junutula As Vice President Of Antibody Discovery & Development 5/12/2014 7:17:29 AM
Cellerant Therapeutics, Inc. Awarded SBIR Contract Funding to Develop CLT-009 for Treatment of Thrombocytopenia 10/8/2012 9:52:09 AM
Cellerant Therapeutics, Inc. Awarded $36.4 Million Option Under Existing U.S. Government Contract to Support Development of CLT-008 for Treatment of Acute Radiation Syndrome 9/4/2012 10:02:48 AM
Cellerant Therapeutics, Inc. to Present at the International Society for Stem Cell Research 10th Annual Meeting in Japan 6/15/2012 10:23:37 AM
Cellerant Therapeutics, Inc. Appoints Gisela Schwab, M.D., to Its Board of Directors and Names Lowell Sears as Chairman of the Board 6/15/2012 10:06:24 AM
Cellerant Therapeutics, Inc. Announces Publication Demonstrating Significant Survival Benefits and Preclinical Proof of Concept With Myeloid Progenitors as Radiation Countermeasure 5/14/2012 10:14:37 AM
Cellerant Therapeutics, Inc. Appoints Lowell E. Sears to Board of Directors 2/21/2012 7:26:29 AM
Cellerant Therapeutics, Inc. Awarded Additional $16.7 Million From US Government 9/15/2011 7:37:33 AM
123